U.S. market Closed. Opens in 16 hours 59 minutes

PSTX | Poseida Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue64.70M130.36M31.24KN/AN/AN/A2.98M9.77M
Cost of Revenue156.77M5.17M4.55M2.59M1.19M689.00KN/AN/A
Gross Profit-92.07M125.19M-4.52M-2.59M-1.19M-689.00K2.98M9.77M
Operating Expenses194.21M190.44M172.65K126.55K78.85M40.56M24.58M15.00M
Selling, General & Admin37.44M37.54M35.91K23.03K18.46M9.67M5.48M5.13M
Research & Development156.77M152.90M136.73K103.52K60.39M30.88M19.10M9.86M
Other Operating ExpensesN/A2.86M19.80K280.002.56M-821.00K37.00KN/A
Operating Income-129.50M-59.95M-141.41K-126.55K-85.53M-41.99M-19.67M-5.45M
Other Expenses / Income6.18M-3.51M16.44M-129.65M-7.68M-2.62M1.40M109.00K
Before Tax Income-123.32M-63.46M-124.97K-129.78K-86.53M-44.61M-20.19M-5.34M
Income Tax Expenses107.00K544.00K-4.53M-2.58M6.11M-202.00K-527.00K-765.00K
Net Income-123.43M-64.00M4.40M2.45M-92.64M-44.40M-19.66M-4.58M
Interest Expenses8.67M6.37M3.36K3.51K3.55M1.80M558.00KN/A
Basic Shares Outstanding90.19M71.91M62.18M36.00M39.73M35.93M39.73M59.32M
Diluted Shares Outstanding90.19M71.95M62.24M36.00M39.73M35.93M39.73M59.32M
EBITDA-109.04M-54.77M-117.06M-145.48M-91.68M-45.12M-20.88M-5.12M
EBITDA Margin-168.52%-42.02%-374,748.70%0.00%0.00%0.00%-699.50%-52.42%
EBIT-114.65M-57.09M-121.62K-126.27K-82.97M-42.81M-19.63M-5.34M
EBIT Margin-177.20%-43.79%-389.32%0.00%0.00%0.00%-657.65%-54.67%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙